SCYNEXIS, Inc. (SCYX) Revenue Growth
SCYNEXIS, Inc. (SCYX) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2019-12-31 | -52.92% |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | -61.32% |
| 2023-12-31 | 2652.72% |
| 2024-12-31 | -97.33% |
| 2025-12-31 | 449.95% |
How SCYX compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| INMB | INmune Bio Inc. | 257.14% |
| VSTM | Verastem Inc. | 209.14% |
| ABEO | Abeona Therapeutics Inc. | 147.52% |
| ALT | Altimmune Inc. | 105.00% |
| RGNX | REGENXBIO Inc. | 104.54% |
These are five companies in the same sector as SCYX with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get SCYNEXIS, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("SCYX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SCYX | $5.39 | -2.36% | 0.06M |
| 3 | ||||
| 4 | ||||
| 5 |